Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 12:33 AM
NCT ID:
NCT03158467
Eligibility Criteria:
Inclusion Criteria:
The inclusion criteria for Phase I (primary objective) are as follows:
* Age ≥ 18 years
* Hematologic malignancy diagnosis including any subset of myeloma, lymphoma, leukemia, or myelodysplastic syndrome
* Currently scheduled for autologous or allogeneic transplant at the Hospital of the University of Pennsylvania
The inclusion criteria for Phase II (secondary objective) are as follows:
* Age ≥ 18 years
* Hematologic malignancy diagnosis including any subset of lymphoma, leukemia, or myelodysplastic syndrome
* Received an autologous or allogeneic stem cell transplant at the Hospital of the University of Pennsylvania and experienced a sentinel event of either 1) disease relapse,2) severe (Grade III or IV) graft-versus-host disease, or 3) unplanned hospital admission with length of stay greater than 72 hours.
Exclusion Criteria:
The exclusion criteria for Phase I include:
* Inability to read and write English
* Not serving as the primary decision maker for their health-related decisions
* Having a non-hematologic malignancy reason for undergoing transplantation (e.g. aplastic anemia)
The exclusion criteria for Phase II include:
* Not completing participation in Phase I of the study
* Myeloma diagnosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03158467
Study Brief:
Protocol Section:
NCT03158467